Prediagnostic sex steroid hormones in relation to male breast cancer risk

Journal of Clinical Oncology

Volumn 33, Issue 18, 2015, Pages 2041-2050

  Brinton, Louise A ^a   Key, Tim J ^c   Kolonel, Laurence N ^e   Michels, Karin B ^f,g   Sesso, Howard D ^g   Ursin, Giske ^h,i,j,k,l,m   Van Den Eeden, Stephen K ⁿ   Wood, Shannon N ^a   Falk, Roni T ^a   Parisi, Dominick ^b   Guillemette, Chantal ^o   Caron, Patrick ^o   Turcotte, Véronique ^o   Habel, Laurel A ⁿ   Isaacs, Claudine J ^p   Riboli, Elio ^d   Weiderpass, Elisabete ^i,j,k,l   Cook, Michael B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF HAWAII   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h UNIVERSITY OF OSLO   (Norway)

ⁱ CANCER REGISTRY OF NORWAY   (Norway)

^j UNIVERSITY OF TROMSØ   (Norway)

^k KAROLINSKA INSTITUTE   (Sweden)

^l FOLKHÄLSAN RESEARCH CENTER   (Finland)

^m UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁿ KAISER PERMANENTE   (United States)

^o LAVAL UNIVERSITY   (Canada)

^p GEORGETOWN UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTRADIOL; ESTROGEN; HORMONE; SEX HORMONE;

ADULT; AGE; AGED; ANDROGEN BLOOD LEVEL; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER RISK; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; HUMAN; MALE; MALE BREAST CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; RANDOMIZED CONTROLLED TRIAL; BLOOD; BREAST NEOPLASMS, MALE; COHORT ANALYSIS; INTERNATIONAL COOPERATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTOR;

AGED; ANDROGENS; BREAST NEOPLASMS, MALE; CASE-CONTROL STUDIES; COHORT STUDIES; ESTRADIOL; GONADAL STEROID HORMONES; HORMONES; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTORS;

EID: 84930621924     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.59.1602     Document Type: Article

References (56)

1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA Cancer J Clin 63:11-30, 2013
2. Evans DG, Susnerwala I, Dawson J, et al: Risk of breast cancer in male BRCA2 carriers. J Med Genet 47:710-711, 2010
3. Bernstein L: Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia 7:3-15, 2002
4. Brinton LA, Richesson DA, Gierach GL, et al: Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst 100:1477-1481, 2008
5. Brinton LA, Cook MB, McCormack V, et al: Anthropometric and hormonal risk factors for male breast cancer: Male breast cancer pooling project results. J Natl Cancer Inst 106:djt465, 2014
6. D'Avanzo B, La Vecchia C: Risk factors for male breast cancer. Br J Cancer 71:1359-1362, 1995
7. Ewertz M, Holmberg L, Tretli S, et al: Risk factors for male breast cancer: A case-control study from Scandinavia. Acta Oncol 40:467-471, 2001
8. Guénel P, Cyr D, Sabroe S, et al: Alcohol drinking may increase risk of breast cancer in men: A European population-based case-control study. Cancer Causes Control 15:571-580, 2004
9. Hsing AW, McLaughlin JK, Cocco P, et al: Risk factors for male breast cancer (United States). Cancer Causes Control 9:269-275, 1998
10. Johnson KC, Pan S, Mao Y: Risk factors for male breast cancer in Canada, 1994-1998. Eur J Cancer Prev 11:253-263, 2002
11. Kanhai RC, Hage JJ, van Diest PJ, et al: Short-term and long-term histologic effects of castration and estrogen treatment on breast tissue of 14 male-to-female transsexuals in comparison with two chemically castrated men. Am J Surg Pathol 24:74-80, 2000
12. Medras M, Filus A, Jozkow P, et al: Breast cancer and long-term hormonal treatment of male hypogonadism. Breast Cancer Res Treat 96:263-265, 2006
13. Symmers WS: Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics. BMJ 2:83-85, 1968
14. Thomas SR, Evans PJ, Holland PA, et al: Invasive breast cancer after initiation of testosterone replacement therapy in a man: A warning to endocrinologists. Endocr Pract 14:201-203, 2008
15. Thomas DB, Jimenez LM, McTiernan A, et al: Breast cancer in men: Risk factors with hormonal implications. Am J Epidemiol 135:734-748, 1992
16. Brinton LA: Breast cancer risk among patients with Klinefelter syndrome. Acta Paediatr 100:814-818, 2011
17. Paduch DA, Fine RG, Bolyakov A, et al: New concepts in Klinefelter syndrome. Curr Opin Urol 18:621-627, 2008
18. Swerdlow AJ, Schoemaker MJ, Higgins CD, et al: Cancer incidence and mortality in men with Klinefelter syndrome: A cohort study. J Natl Cancer Inst 97:1204-1210, 2005
19. Key TJ: Endogenous oestrogens and breast cancer risk in premenopausal and postmenopausal women. Steroids 76:812-815, 2011
20. Key TJ, Appleby PN, Reeves GK, et al: Sex hormones and risk of breast cancer in premenopausal women: A collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol 14:1009-1019, 2013
21. Cutler JL, Ramcharan S, Feldman R, et al: Multiphasic checkup evaluation study: 1. Methods and population. Prev Med 2:197-206, 1973
22. Giovannucci E, Rimm EB, Liu Y, et al: Body mass index and risk of prostate cancer in U.S. health professionals. J Natl Cancer Inst 95:1240-1244, 2003
23. Jellum E, Andersen A, Lund-Larsen P, et al: The JANUS serum bank. Sci Total Environ 139-140:527-535, 1993
24. Kolonel LN, Henderson BE, Hankin JH, et al: A multiethnic cohort in Hawaii and Los Angeles: Baseline characteristics. Am J Epidemiol 151:346-357, 2000
25. Prorok PC, Andriole GL, Bresalier RS, et al: Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. Control Clin Trials 21:273S-309S, 2000 (suppl)
26. Riboli E, Hunt KJ, Slimani N, et al: European Prospective Investigation Into Cancer and Nutrition (EPIC): Study populations and data collection. Public Health Nutr 5:1113-1124, 2002
27. Sesso HD, Gaziano JM, VanDenburgh M, et al: Comparison of baseline characteristics and mortality experience of participants and nonparticipants in a randomized clinical trial: The Physicians' Health Study. Control Clin Trials 23:686-702, 2002
28. Birmann BM, Neuhouser ML, Rosner B, et al: Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium. Blood 120:4929-4937, 2012
29. Mark SD, Qiao YL, Dawsey SM, et al: Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 92:1753-1763, 2000
30. Eriksson AL, Lorentzon M, Vandenput L, et al: Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men. J Clin Endocrinol Metab 94:1033-1041, 2009
31. Huhtaniemi IT, Tajar A, Lee DM, et al: Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry: Relevance for the diagnostics in aging men. Eur J Endocrinol 166:983-991, 2012
32. Lee DM, Ulubaev A, Tajar A, et al: Endogenous hormones, androgen receptor CAG repeat length and fluid cognition in middle-aged and older men: Results from the European Male Ageing Study. Eur J Endocrinol 162:1155-1164, 2010
33. Dallal CM, Tice JA, Buist DS, et al: Estrogen metabolism and breast cancer risk among postmenopausal women: A case-cohort study within B-FIT. Carcinogenesis 35:346-355, 2014
34. Falk RT, Brinton LA, Dorgan JF, et al: Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: A nested case-control study. Breast Cancer Res 15:R34, 2013
35. Fuhrman BJ, Schairer C, Gail MH, et al: Estrogen metabolism and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 104:326-339, 2012
36. Kaaks R, Tikk K, Sookthai D, et al: Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status: Results from the EPIC cohort. Int J Cancer 134:1947-1957, 2014
37. Yager JD: Mechanisms of estrogen carcinogenesis: The role of E2/E1-quinone metabolites suggests new approaches to preventive intervention-A review. Steroids. [epub ahead of print on August 24, 2014]
38. Yue W, Yager JD, Wang JP, et al: Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis. Steroids 78:161-170, 2013
39. Simpson ER, Clyne C, Rubin G, et al: Aromatase: A brief overview. Annu Rev Physiol 64:93-127, 2002
40. Chavez-Macgregor M, Clarke CA, Lichtensztajn D, et al: Male breast cancer according to tumor subtype and race: A population-based study. Cancer 119:1611-1617, 2013
41. James RE, Lukanova A, Dossus L, et al: Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: A nested case-control study. Cancer Prev Res (Phila) 4:1626-1635, 2011
42. Popli MB, Popli V, Bahl P, et al: Pictorial essay: Mammography of the male breast. Indian J Radiol Imaging 19:278-281, 2009
43. Braunstein GD: Clinical practice: Gynecomastia. N Engl J Med 357:1229-1237, 2007
44. Weiss JR, Moysich KB, Swede H: Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev 14:20-26, 2005
45. Wikström AM, Dunkel L: Testicular function in Klinefelter syndrome. Horm Res 69:317-326, 2008
46. Wosnitzer MS, Paduch DA: Endocrinological issues and hormonal manipulation in children and men with Klinefelter syndrome. Am J Med Genet C Semin Med Genet 163C:16-26, 2013
47. Key TJ, Appleby PN, Reeves GK, et al: Circulating sex hormones and breast cancer risk factors in postmenopausal women: Reanalysis of 13 studies. Br J Cancer 105:709-722, 2011
48. Key TJ, Appleby PN, Reeves GK, et al: Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95:1218-1226, 2003
49. Rinaldi S, Key TJ, Peeters PH, et al: Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: A study within the EPIC cohort. Int J Cancer 118:2832-2839, 2006
50. Beral V: Breast cancer and hormonereplacement therapy in the Million Women Study. Lancet 362:419-427, 2003
51. Brinton LA, Richesson D, Leitzmann MF, et al: Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Epidemiol Biomarkers Prev 17:3150-3160, 2008
52. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer-Collaborative group on hormonal factors in breast cancer. Lancet 350:1047-1059, 1997
53. Finkelstein JS, Lee H, Burnett-Bowie SA, et al: Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med 369:1011-1022, 2013
54. Jasuja GK, Travison TG, Davda M, et al: Age trends in estradiol and estrone levels measured using liquid chromatography tandem mass spectrometry in community-dwelling men of the Framingham Heart Study. J Gerontol A Biol Sci Med Sci 68:733-740, 2013
55. Trabert B, Graubard BI, Nyante SJ, et al: Relationship of sex steroid hormones with body size and with body composition measured by dualenergy X-ray absorptiometry in US men. Cancer Causes Control 23:1881-1891, 2012
56. Jatoi I, Anderson WF: Qualitative age interactions in breast cancer studies: A mini-review. Future Oncol 6:1781-1788, 2010